CoChat

Association of sleep duration at age 50, 60, and 70 years with risk of multimorbidity in the UK: 25-year follow-up of the Whitehall II cohort study

Open access
Sabia, Séverine, Dugravot, Aline, Léger, Damien, Ben Hassen, Céline, Kivimaki, Mika, Singh-Manoux, Archana · 2022 · PLOS Medicine

The DOI matches its Crossref record; 40 of the 41 references it cites were found in a registry or an index.

Abstract

Background: Sleep duration has been shown to be associated with individual chronic diseases but its association with multimorbidity, common in older adults, remains poorly understood. We examined whether sleep duration is associated with incidence of a first chronic disease, subsequent multimorbidity and mortality using data spanning 25 years. Methods and findings: Data were drawn from the prospective Whitehall II cohort study, established in 1985 on 10,308 persons employed in the London offices of the British civil service. Self-reported sleep duration was measured 6 times between 1985 and 2016, and data on sleep duration was extracted at age 50 (mean age (standard deviation) = 50.6 (2.6)), 60 (60.3 (2.2)), and 70 (69.2 (1.9)). Incidence of multimorbidity was defined as having 2 or more of 13 chronic diseases, follow-up up to March 2019. Cox regression, separate analyses at each age, was used to examine associations of sleep duration at age 50, 60, and 70 with incident multimorbidity. Multistate models were used to examine the association of sleep duration at age 50 with onset of a first chronic disease, progression to incident multimorbidity, and death. Analyses were adjusted for sociodemographic, behavioral, and health-related factors. A total of 7,864 (32.5% women) participants free of multimorbidity had data on sleep duration at age 50; 544 (6.9%) reported sleeping ≤5 hours, 2,562 (32.6%) 6 hours, 3,589 (45.6%) 7 hours, 1,092 (13.9%) 8 hours, and 77 (1.0%) ≥9 hours. Compared to 7-hour sleep, sleep duration ≤5 hours was associated with higher multimorbidity risk (hazard ratio: 1.30, 95% confidence interval = 1.12 to 1.50; p < 0.001). This was also the case for short sleep duration at age 60 (1.32, 1.13 to 1.55; p < 0.001) and 70 (1.40, 1.16 to 1.68; p < 0.001). Sleep duration ≥9 hours at age 60 (1.54, 1.15 to 2.06; p = 0.003) and 70 (1.51, 1.10 to 2.08; p = 0.01) but not 50 (1.39, 0.98 to 1.96; p = 0.07) was associated with incident multimorbidity. Among 7,217 participants free of chronic disease at age 50 (mean follow-up = 25.2 years), 4,446 developed a first chronic disease, 2,297 progressed to multimorbidity, and 787 subsequently died. Compared to 7-hour sleep, sleeping ≤5 hours at age 50 was associated with an increased risk of a first chronic disease (1.20, 1.06 to 1.35; p = 0.003) and, among those who developed a first disease, with subsequent multimorbidity (1.21, 1.03 to 1.42; p = 0.02). Sleep duration ≥9 hours was not associated with these transitions. No association was found between sleep duration and mortality among those with existing chronic diseases. The study limitations include the small number of cases in the long sleep category, not allowing conclusions to be drawn for this category, the self-reported nature of sleep data, the potential for reverse causality that could arise from undiagnosed conditions at sleep measures, and the small proportion of non-white participants, limiting generalization of findings. Conclusions: In this study, we observed short sleep duration to be associated with risk of chronic disease and subsequent multimorbidity but not with progression to death. There was no robust evidence of an increased risk of chronic disease among those with long sleep duration at age 50. Our findings suggest an association between short sleep duration and multimorbidity.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1371/journal.pmed.1004109

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig 1 Schematic representation of the transitions from start of follow-up (free of chronic disease at age 50) to a first chronic disease, multimorbidity, and mortality. Transition A represents the transition from a healthy state at age 50 (free of the 13 chronic diseases considered) to a first chronic disease (any from the list of 13 diseases considered); Transition B represents the transition from a healthy state to death among those who remained free from any of the 13 diseases during follow-up; Transition C represents the transition from a first chronic disease to multimorbidity (occurrence of a second disease among those with 1 chronic disease); Transition D represents the transition from a first chronic disease to death among those who remained free from multimorbidity during the follow-up; and Transition E represents the transition from multimorbidity to death.
Fig 1 Schematic representation of the transitions from start of follow-up (free of chronic disease at age 50) to a first chronic disease, multimorbidity, and mortality. Transition A represents the transition from a healthy state at age 50 (free of the 13 chronic diseases considered) to a first chronic disease (any from the list of 13 diseases considered); Transition B represents the transition from a healthy state to death among those who remained free from any of the 13 diseases during follow-up; Transition C represents the transition from a first chronic disease to multimorbidity (occurrence of a second disease among those with 1 chronic disease); Transition D represents the transition from a first chronic disease to death among those who remained free from multimorbidity during the follow-up; and Transition E represents the transition from multimorbidity to death.CC BY · PubMed Central
Fig 2 Flowchart for analyses on the association between sleep duration at age 50, 60, and 70 and risk of multimorbidity.
Fig 2 Flowchart for analyses on the association between sleep duration at age 50, 60, and 70 and risk of multimorbidity.CC BY · PubMed Central
Fig 3 Association of accelerometer assessed sleep duration in 2012–2013 (age range, 60 to 83 years) with risk of incident multimorbidity (N cases/N total = 601/3,368) over a mean follow-up of 6.0 (SD = 1.6) years. Multimorbidity defined as 2 or more of the following chronic diseases: diabetes, cancer, coronary heart disease, stroke, heart failure, chronic obstructive pulmonary disease, chronic kidney disease, liver disease, depression, dementia, other mental disorder, Parkinson’s disease, and arthritis/rheumatoid arthritis. (A) Model unadjusted (age as timescale). (B) Model adjusted for age (timescale), sex, ethnicity, education, occupational position, and marital status. (C) Model additionally adjusted for alcohol consumption, physical activity, smoking status, fruit and vegetable consumption, BMI, hypertension, use of sleep medication, and prevalence of 1 of the 13 chronic diseases. (D) Sleep duration distribution among participants with no incident multimorbidity (blue) and those with incident multimorbidity (brown).
Fig 3 Association of accelerometer assessed sleep duration in 2012–2013 (age range, 60 to 83 years) with risk of incident multimorbidity (N cases/N total = 601/3,368) over a mean follow-up of 6.0 (SD = 1.6) years. Multimorbidity defined as 2 or more of the following chronic diseases: diabetes, cancer, coronary heart disease, stroke, heart failure, chronic obstructive pulmonary disease, chronic kidney disease, liver disease, depression, dementia, other mental disorder, Parkinson’s disease, and arthritis/rheumatoid arthritis. (A) Model unadjusted (age as timescale). (B) Model adjusted for age (timescale), sex, ethnicity, education, occupational position, and marital status. (C) Model additionally adjusted for alcohol consumption, physical activity, smoking status, fruit and vegetable consumption, BMI, hypertension, use of sleep medication, and prevalence of 1 of the 13 chronic diseases. (D) Sleep duration distribution among participants with no incident multimorbidity (blue) and those with incident multimorbidity (brown).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 40 references

Research works printed but not linked: 2

  1. World Health Organisation., 2016, Multimorbidity: Technical Series on Safer, Primary Care
  2. Springer, 2001

Cited by

See all 106

Metadata

Authors
Sabia, S., Dugravot, A., Léger, D., Ben Hassen, C., Kivimaki, M., & Singh-Manoux, A.
Affiliations
  • Inserm (FR)
  • Université Paris Cité (FR)
Venue
PLOS Medicine
Published
2022-10-18
Volume
19
Issue
10
Pages
e1004109
ISSN
  • 1549-1277 (ISSN-L)
  • 1549-1676
OpenAlex
W4306732432
Cited by
106
References
41
Citations by year
2026: 23 · 2025: 30 · 2024: 35 · 2023: 17 · 2022: 1
FWCI
19.10
Type
journal article
Language
en
Open access
Locations
  • PLoS Medicine (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • UCL Discovery (University College London) (submittedVersion)
  • Työväentutkimus Vuosikirja (submittedVersion)
Funders
  • National Institute on Aging (R01AG056477, RF1AG062553)
  • Medical Research Foundation (R024227, S011676, K013351)
  • British Heart Foundation (RG/16/11/32334)
  • Wellcome Trust (221854/Z/20/Z)
  • Agence Nationale de la Recherche (ANR-19-CE36-0004-01)
Topics
  • Social Sciences › Psychology › Experimental and Cognitive Psychology › Sleep and related disorders
  • Health Sciences › Medicine › Epidemiology › Chronic Disease Management Strategies
  • Health Sciences › Medicine › Physiology (medical) › Obstructive Sleep Apnea Research
Keywords
sleep duration, multimorbidity, chronic disease incidence, older adults, short sleep duration, long sleep, mortality, Whitehall II cohort, civil service employees, sleep and health, disease progression, multi-state models, self-reported sleep, socioeconomic status, alcohol consumption, physical activity
MeSH terms
Multimorbidity, Aged, Female, Follow-Up Studies, Humans, London, Male, Middle Aged, Prospective Studies, Risk Factors, Sleep, Sleep Wake Disorders, Cohort Studies

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Association of sleep duration at age 50, 60, and 70 years with risk of multimorbidity in the UK: 25-year follow-up of the Whitehall II cohort study. https://app.cochat.ai/papers/10.1371/journal.pmed.1004109
The paper
Sabia, S., Dugravot, A., Léger, D., Ben Hassen, C., Kivimaki, M., & Singh-Manoux, A. (2022). Association of sleep duration at age 50, 60, and 70 years with risk of multimorbidity in the UK: 25-year follow-up of the Whitehall II cohort study. PLOS Medicine. https://doi.org/10.1371/journal.pmed.1004109

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.